- Home
- Products
Andexxa (Ondexxya)
Andexxa (Ondexxya)
- Medicine Name: Andexxa (US) / Ondexxya (EU)
- Generic Name: Andexanet Alfa
- Dosage Form & Strength: 200 mg lyophilized powder in single-use vial for intravenous injection
- Manufactured By: Alexion Pharmaceuticals, Inc. / Portola Pharmaceuticals UK Ltd.
Andexanet Alfa is a recombinant modified human Factor Xa (FXa) protein used to reverse life-threatening or uncontrolled bleeding in adult patients receiving FXa inhibitor anticoagulants such as apixaban or rivaroxaban.
Recommended Dosage:
- Low Dose Regimen:
- IV bolus: 400 mg at 30 mg/min
- Continuous IV infusion: 4 mg/min for up to 120 minutes
- IV bolus: 400 mg at 30 mg/min
- High Dose Regimen:
- IV bolus: 800 mg at 30 mg/min
- Continuous IV infusion: 8 mg/min for up to 120 minutes
- IV bolus: 800 mg at 30 mg/min
Administration Note: Use an in-line 0.2 or 0.22-micron filter. Do not mix with other medications.
Thromboembolic Risk: Monitor patients for arterial/venous thrombosis and resume anticoagulation therapy as soon as clinically appropriate.
Heparin Interaction: Do not use Andexxa/Ondexxya prior to heparin therapy; may reduce heparin effectiveness.
Infusion Reactions: Observe patients for mild/moderate reactions. Interrupt or slow infusion rate as needed.
Pregnancy & Breastfeeding: Not recommended during pregnancy. Discontinue breastfeeding during treatment.
Contraception Required for women of reproductive potential during therapy.
To import Andexxa/Ondexxya into India, the following documents are required:
- Valid prescription from a licensed doctor
- Diagnostic reports confirming need
- Government-issued ID proof of the patient
- Import permit (if applicable)
Order confirmation is processed only after all documents are verified.
GlobalRareMeds, in partnership with Indian Pharma Network, ensures authentic sourcing and secure global delivery of Andexxa / Ondexxya 200 mg.
- Sourced from USA, Europe, UK, Canada, and Australia
- Handled by WHO-GDP and ISO 9001:2008 certified suppliers
- Dispensed and shipped from Ambernath, Thane District, India
- Full cold chain and import compliance managed
📞 Call/WhatsApp: +91-99675 15602
📧 Email: info@globalraremeds.com
Q. What is Andexanet Alfa used for?
A. It is used to reverse the effects of blood thinners like apixaban or rivaroxaban during emergency bleeding situations.
Q. What are the trade names?
A. Andexxa® (US) and Ondexxya® (EU).
Q. Who manufactures it?
A. Alexion Pharmaceuticals, Inc. (US) and Portola Pharmaceuticals UK Ltd. (EU).
Q. How is Andexanet Alfa administered?
A. As an intravenous bolus followed by a 2-hour continuous infusion.
Q. Is it FDA approved?
A. Yes, Andexxa was approved by the FDA in May 2018.
Q. What are the common side effects?
A. Infusion reactions, urinary tract infections, and pneumonia.
Q. What are the storage conditions?
A. Refrigerate at 2–8°C (36–46°F). Do not freeze.
Q. How much does it cost in India?
A. Pricing varies based on availability. Contact GlobalRareMeds for the best rates.
Q. Can I legally import Andexxa/Ondexxya into India?
A. Yes, under the Named Patient Program, it can be legally imported with proper documentation.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
